# PLATFORM_VALIDATION_REPORT.md

**Validation run:** RUN-20260706-002 (OrangeHRM, Login + PIM scope) — the Agentic AI Testing Platform's **first complete Stage 1→6 execution**, exercising every checkpoint type defined in `pipeline/pipeline.md` §5.
**Date:** 2026-07-06.
**Object under test:** the platform's own pipeline machinery — agent specs, checkpoints, Run Manager, artifact traceability. **Not** a QA engagement on OrangeHRM itself; application-level findings are secondary evidence of the pipeline working, not this report's subject.
**Prior context:** `RUN-20260706-001` (also OrangeHRM, Login-only scope) preceded this run, reached Stage 2, and was left there — see "Missing Artifacts" below. It is referenced for context, not re-validated here.

---

## 1. Completed Stages

All 6 stages completed, in order, for RUN-20260706-002:

| Stage | Agent Spec Version | Checkpoint | Cleared By |
|---|---|---|---|
| 1 — Project Context | v1 (unchanged) | Human Review Required | Aymoon, Business Analyst / Product Owner role |
| 2 — Explorer | v2 | Human Review Required | Aymoon, QA Lead role |
| 3 — Test Design | v2 | Human Review Required | Aymoon, QA Architect / Test Lead role |
| 4 — Automation | v2 | Automation Approval Required | Aymoon, Automation Lead / Release Manager role |
| 5 — Execution | v1 (unchanged) | None (mechanical, per spec) | n/a |
| 6 — Reporting | v1 (unchanged) | None (terminal, per spec) | n/a |

No stage was invoked while its predecessor's checkpoint was open. No checkpoint was auto-approved, inferred, or timed out — every "Human Review Required" and the one "Automation Approval Required" gate was explicitly granted by name, in a separate message, before the next stage began.

## 2. Failed Stages

**None.** Every stage produced its full set of required artifacts. This is distinct from — and should not be confused with — Stage 5's mechanical test outcomes (12 Passed / 12 Failed / 1 Skipped at the *test* level), which are normal, expected execution data, not a pipeline-stage failure. The pipeline's job was to run the suite and record what happened; it did that successfully even though many individual tests within the suite did not pass.

## 3. Skipped Stages

**None.** All 6 stages ran, in full, in order — no stage was bypassed, and no stage's output was assumed rather than produced.

## 4. Architecture Violations

Ranked by significance. "Violation" here means *a deviation from what a spec document literally says*, not necessarily a harmful outcome — several of these were deliberate, disclosed, necessary adaptations.

1. **Artifact location.** Every agent spec's "Expected Artifacts" table names a flat path (`artifacts/OrangeHRM/{discovery,findings,testcases,Automation,execution,Reports}/...`). This run generated everything under `artifacts/OrangeHRM/runs/RUN-20260706-002/...` instead, to avoid colliding with a pre-existing legacy artifact at one of those flat paths (`Reports/QA_Assessment_Report.md`). This was disclosed at the point of decision each time, and only the Stage 1 Project Context's "current-approved pointer" was ever promoted to its flat path (correctly, per `pipeline/pipeline.md` §7's own versioning rule). No spec currently documents this as expected behavior — see Lesson 7 in `LESSONS_LEARNED.md`.
2. **An extra process pause not defined by any checkpoint type.** Per explicit instruction, this run paused between Stage 5 (Execution) and Stage 6 (Reporting) for confirmation before Reporting was invoked. `pipeline/pipeline.md` defines exactly two gate types (Human Review Required, Automation Approval Required) and states Stage 5 has no checkpoint and Stage 6 is terminal — neither literally covers a Stage 5→6 pause. It was honored as a reasonable operator instruction, not mischaracterized as one of the two defined gate types.
3. **`pipeline/run_manager.md` §6's Workspace Structure has no defined subfolder for Stage 3/4/5 outputs.** `testcases/`, `Automation/`, and `execution/` were added to the Run Workspace as a minimal, undocumented extension (see Lesson 8).
4. **Tooling dependencies not present in the repository were installed mid-pipeline:** `exceljs` (Stage 3, for real `.xlsx` output — no Python or spreadsheet library existed) and `@playwright/test` (Stage 5, for the test runner — the repo only had the base `playwright` library, used for MCP browser automation, not the test-runner package). Both installs were scoped locally (`--no-save` for `exceljs`; a separate `package.json` inside the Automation Package for `@playwright/test`) and disclosed at the time.
5. **The Final QA Report used a 12-section structure**, per explicit instruction, rather than `agents/reporting_agent.md` §8's literally-specified 8-section structure. Every one of the 8 required elements is present, folded into the 12 sections (e.g., "Detailed Execution Report" → "Execution Summary"; "Defect Summary" → "Findings Summary"); nothing required was dropped, but the section *names* deviate from spec.

## 5. Missing Artifacts

1. **The flat, canonical per-project paths for Stages 2–6 of RUN-20260706-002 contain nothing** (per Architecture Violation #1) — a future reader checking `artifacts/OrangeHRM/testcases/`, `artifacts/OrangeHRM/Automation/`, `artifacts/OrangeHRM/execution/`, or `artifacts/OrangeHRM/Reports/OrangeHRM_Final_QA_Report.md` directly, without knowing to look inside `runs/RUN-20260706-002/`, will find this run's work absent from where every spec says it should be.
2. **`RUN-20260706-001` never advanced past Stage 2.** Its Stage 1 Project Context (v1) was approved; its Stage 2 Explorer output (`QA_Assessment_Report.md`, 4 Findings) was generated and presented for review, but the conversation moved on to platform-upgrade work before that checkpoint was ever explicitly cleared. It remains, to date, an open, un-continued run — not broken, just dangling.
3. **No `.xlsx` test suites exist for the *legacy*-pipeline OrangeHRM modules** (Admin/PIM/Leave under the old 4-stage pipeline) — a gap that predates this validation run entirely (noted in `SESSION_HANDOFF.md` before this session) and remains unaddressed, since this run's scope was the new pipeline, not legacy backfill.

## 6. Broken Traceability

**None found.** The full chain — PRD → Project Context → Discovery → Finding → Evidence → Manual Test Case → Automation Script → Execution Result → Final QA Report — was traced successfully for all 6 Findings and all 25 test cases in RUN-20260706-002:

- Every Finding (`FINDING-001`–`006`) traces to its Discovery snapshot and Project Context Carried-Forward Risk.
- Every test case (`TC-LOGIN-001`–`011`, `TC-PIM-001`–`014`) carries a Requirement Reference and Discovery Reference (per `agents/test_design_agent.md` §5.1); every Finding-derived case additionally carries a Finding Reference and Evidence Reference.
- Every Automation Script cites its Test Case ID and inherits (without alteration) that test case's references, per `agents/automation_agent.md` §12.
- Every Execution Result cites its Test Case ID and Automation Script ID, per `agents/execution_agent.md` §7 Rule 7.
- The Final QA Report's Findings Summary and Requirement Coverage sections walk this chain back to source for every item, per `agents/reporting_agent.md` §12.

One near-miss, not a break: the Stage 4 `AutomationCoverageReport.md`'s own summary arithmetic (21) disagreed with its sibling `AutomationDecisionReport.md`'s detail table (22) — an internal consistency issue *within* one stage's own outputs, not a broken link *between* stages (see Architecture item and Lesson 11 in `LESSONS_LEARNED.md`). Flagged in the Final QA Report, not corrected in place.

## 7. Improvement Recommendations

1. Decide and document, in `pipeline/pipeline.md` or `pipeline/run_manager.md`, whether new-pipeline artifacts default to flat per-project paths or Run-Workspace paths — and under what condition (e.g., collision detected vs. not) — rather than leaving each run's operator to decide ad hoc.
2. Extend `pipeline/run_manager.md` §6's Workspace Structure to formally define subfolders for Stage 3 (`testcases/`), Stage 4 (`Automation/`), and Stage 5 (`execution/`) outputs.
3. Either formalize a named checkpoint between Stage 5 and Stage 6 in `pipeline/pipeline.md`, or explicitly document that none exists and any such pause is operator discretion, not platform-defined.
4. Correct the Stage 4 `OrangeHRM_AutomationCoverageReport.md` arithmetic (21 → 22 Generate New Automation) in a future Stage 4 revision for this run.
5. Investigate and likely revise the automation-layer defects surfaced at Stage 5 (`EmployeeListPage.expandFilterPanel` and related selectors) before treating this suite's PIM regression results as conclusive for `FINDING-003`/`004`/`006`.
6. Consider formalizing the richer 12-section Final QA Report structure actually used this run into `agents/reporting_agent.md` §8, if it proves valuable across future runs, rather than reinventing it per-instruction each time.
7. Add an explicit rule to `agents/reporting_agent.md` requiring regression-test failures to be checked against their raw failure message before being counted as "confirms the Finding" — see Lesson 10.
8. Require any stage that produces both a detail table and a rolled-up summary to compute the summary from the detail table programmatically, or cross-check the two before the artifact is finalized — see Lesson 11.
9. Add explicit guidance that any flakiness/retry-derived statistic must be reported alongside its retry configuration — see Lesson 12.
10. Decide RUN-20260706-001's fate: explicitly close/supersede it, or resume and complete it — an indefinitely dangling run is itself a minor traceability/hygiene risk even though nothing is currently broken by its existence.
11. Establish a timestamp discipline for future runs: query the system clock explicitly at run start and derive all subsequent artifact timestamps from elapsed/relative time, rather than narrative estimation (this run's Stage 1–4 artifacts used timestamps that drifted from the actual system clock observed when Stage 5 first queried it).

## 8. Lessons Learned

Full detail, each with a "what happened / why it matters / recommended fix" structure, is recorded in `LESSONS_LEARNED.md` §7–12 (added as part of this validation run, appended to — never overwriting — the pre-existing architectural lessons from the platform's design phase, §1–6). Headline list:

7. The flat-path/legacy-collision problem predicted during design recurred concretely, on the platform's own new artifacts.
8. A component's own worked example (here, `run_manager.md`'s First Run) silently caps what it visibly supports beyond that example's own scope.
9. Self Review's pre-flagged risk (a specific selector) became the actual, dominant execution failure — validating the step's real predictive value.
10. A regression test's failure *mode* matters as much as its verdict — "failed" is not automatically "confirms the bug."
11. A stage's own summary table and detail table can silently disagree, with nothing currently cross-checking a stage against itself.
12. A flakiness statistic computed with retries disabled measures nothing — "0 Flaky" needs its retry configuration stated alongside it to mean anything.

---

*This report is the terminal deliverable of the platform's first end-to-end validation exercise. It does not itself trigger any further pipeline stage and is intended for human stakeholders and future platform-maintenance sessions, consistent with how `agents/reporting_agent.md` §11 frames the Final QA Report's own terminal role.*
